Back to BR Brookstone Capital Management

NVONVO

Showing 8 of 28 quarters

Position history for BRBrookstone Capital Management's holdings in Novo Nordisk A/S

Yes. Brookstone Capital Management holds 12,845 shares of NVO (Novo Nordisk), worth $486,943, as of its Q3 2026 13F filing. It reduced the position by 10 shares (-0.1%) from Q2 2026. Brookstone Capital Management has listed NVO in each of its last 28 quarterly 13F filings.

Current Value

$486,943

Current Shares

12,845

Total Value Change

-$784,902

Total Shares Change

-1,940

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
12,845
-0.1%
$486,9430.0%$37.91
0
2026-Q2
Decreased
12,855
-34.0%
$616,2550.0%$47.34
0
2026-Q1
Increased
19,480
+25.2%
$715,9070.0%$36.29
30
2025-Q4
Decreased
15,555
-34.8%
$791,4240.0%$48.46
0
2025-Q3
Increased
23,853
+8.2%
$1.3M0.0%$52.85
28
2025-Q2
Increased
22,037
+55.3%
$1.5M0.0%$65.01
36
2025-Q1
Decreased
14,189
-4.0%
$985,3160.0%$65.40
0
2024-Q4
Decreased
14,785
-9.9%
$1.3M0.0%$79.73
0

Optional analytics helps us improve. How it’s used